Literature DB >> 32009614

Long-term outcomes of endoscopic resection for non-ampullary duodenal epithelial tumors: A single-center experience.

Kyung Lim Hwang1, Gwang Ha Kim1, Bong Eun Lee1, Moon Won Lee1, Dong Hoon Baek1, Geun Am Song1.   

Abstract

BACKGROUND/AIMS: The malignant potential of non-ampullary duodenal epithelial tumors (NADETs) is lower compared to that of other gastrointestinal epithelial tumors, but it should not be overlooked. Recently, endoscopic resection (ER) has been proposed as an alternative treatment option for NADETs. Therefore, we aimed to analyze the clinical outcomes of ER of NADETs and determine the factors associated with an incomplete resection.
MATERIALS AND METHODS: We conducted a retrospective observational study of 54 patients (56 lesions) with NADETs, who underwent ER in the period between October 2006 and March 2016, and analyzed the therapeutic outcomes and procedure-related adverse events.
RESULTS: Endoscopic mucosal resection (EMR) was performed on 41 lesions, and endoscopic submucosal dissection (ESD) was performed on 15 lesions. The en bloc and complete resection rates were 82% (46/56) and 54% (30/56), respectively. Multivariate logistic regression analyses determined that the resection method (EMR: odds ratio 4.356, 95% confidence interval 1.021-18.585, p=0.047) was independently associated with incomplete resection. The procedure-related bleeding and perforation rates were 4% and 5%, respectively. Recurrence of tumor occurred in one of 44 patients during the median follow-up period of 25 months (range: 6-89 months).
CONCLUSION: ER is an effective, safe, and feasible treatment option for NADETs. However, the incomplete resection rate increases when EMR is performed. Nevertheless, given the longer procedure time and the technical difficulty associated with ESD, and the excellent long-term outcomes associated with EMR, EMR of NADETs is appropriate, especially in patients with dysplastic lesions.

Entities:  

Year:  2020        PMID: 32009614      PMCID: PMC7075677          DOI: 10.5152/tjg.2020.19156

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.852


  28 in total

Review 1.  The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002.

Authors: 
Journal:  Gastrointest Endosc       Date:  2003-12       Impact factor: 9.427

2.  One thousand consecutive pancreaticoduodenectomies.

Authors:  John L Cameron; Taylor S Riall; JoAnn Coleman; Kenneth A Belcher
Journal:  Ann Surg       Date:  2006-07       Impact factor: 12.969

3.  Endoscopic resection of sporadic duodenal adenomas: comparison of endoscopic mucosal resection (EMR) with hybrid endoscopic submucosal dissection (ESD) techniques and the risks of late delayed bleeding.

Authors:  Peter John Basford; Regi George; Emma Nixon; Tehreem Chaudhuri; Rob Mead; Pradeep Bhandari
Journal:  Surg Endosc       Date:  2014-01-18       Impact factor: 4.584

4.  Endoscopic submucosal dissection for duodenal tumors: a single-center experience.

Authors:  S Matsumoto; H Miyatani; Y Yoshida
Journal:  Endoscopy       Date:  2012-08-28       Impact factor: 10.093

5.  Endoscopic mucosal resection of large and giant lateral spreading lesions of the duodenum: success, adverse events, and long-term outcomes.

Authors:  Amir Klein; Dhruv Nayyar; Farzan F Bahin; Zhengyan Qi; Eric Lee; Stephen J Williams; Karen Byth; Michael J Bourke
Journal:  Gastrointest Endosc       Date:  2016-03-11       Impact factor: 9.427

6.  Impact of hospital volume on outcomes for pancreaticoduodenectomy: a single UK HPB centre experience.

Authors:  S Mukherjee; H M Kocher; R R Hutchins; S Bhattacharya; A T Abraham
Journal:  Eur J Surg Oncol       Date:  2008-06-10       Impact factor: 4.424

7.  Usefulness and safety of endoscopic treatment for nonampullary duodenal adenoma and adenocarcinoma.

Authors:  Jung Yeon Seo; Su Jin Hong; Jae Pil Han; Hee Yoon Jang; Yu Sik Myung; Cheol Kim; Yun Nah Lee; Bong Min Ko
Journal:  J Gastroenterol Hepatol       Date:  2014-09       Impact factor: 4.029

8.  Efficacy and safety of endoscopic treatment for nonampullary sporadic duodenal adenomas.

Authors:  Yang Won Min; Byung-Hoon Min; Eun Ran Kim; Jun Haeng Lee; Poong-Lyul Rhee; Jong Chul Rhee; Jae J Kim
Journal:  Dig Dis Sci       Date:  2013-05-22       Impact factor: 3.199

9.  EMR of large, sessile, sporadic nonampullary duodenal adenomas: technical aspects and long-term outcome (with videos).

Authors:  Sina Alexander; Michael J Bourke; Stephen J Williams; Adam Bailey; Jonard Co
Journal:  Gastrointest Endosc       Date:  2008-08-23       Impact factor: 9.427

10.  Feasibility of endoscopic resection for sessile nonampullary duodenal tumors: a multicenter retrospective study.

Authors:  Sung Min Park; Joo Ho Ham; Byung-Wook Kim; Joon Sung Kim; Chang Whan Kim; Jin Il Kim; Chul Hyun Lim; Jung Hwan Oh
Journal:  Gastroenterol Res Pract       Date:  2015-02-24       Impact factor: 2.260

View more
  2 in total

1.  Low recurrence rate after endoscopic resection in non-ampullary duodenal lesions: A 16-year single-center retrospective study.

Authors:  Gyu Man Oh; Hyun Seung Je; Kyoungwon Jung; Jae Hyun Kim; Sung Eun Kim; Won Moon; Moo In Park; Seun Ja Park
Journal:  Medicine (Baltimore)       Date:  2021-06-11       Impact factor: 1.817

2.  Histopathologic discrepancies between endoscopic forceps biopsy and endoscopic resection specimens in nonampullary duodenal epithelial tumors.

Authors:  Da Mi Kim; Gwang Ha Kim; Bong Eun Lee; Kyungbin Kim; Kyung Un Choi; Seung Min Hong; Moon Won Lee; Geun Am Song
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.